Page last updated: 2024-09-05

cilengitide and mk 2206

cilengitide has been researched along with mk 2206 in 1 studies

Compound Research Comparison

Studies
(cilengitide)
Trials
(cilengitide)
Recent Studies (post-2010)
(cilengitide)
Studies
(mk 2206)
Trials
(mk 2206)
Recent Studies (post-2010) (mk 2206)
1942913335528347

Protein Interaction Comparison

ProteinTaxonomycilengitide (IC50)mk 2206 (IC50)
RAC-alpha serine/threonine-protein kinaseHomo sapiens (human)0.008
RAC-beta serine/threonine-protein kinaseHomo sapiens (human)0.012
RAC-gamma serine/threonine-protein kinaseHomo sapiens (human)0.065

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Im, H; Lee, J; Ryu, KY; Yi, JY1

Other Studies

1 other study(ies) available for cilengitide and mk 2206

ArticleYear
Integrin αvβ3-Akt signalling plays a role in radioresistance of melanoma.
    Experimental dermatology, 2020, Volume: 29, Issue:6

    Topics: Cell Line, Tumor; Cell Survival; Gamma Rays; Heterocyclic Compounds, 3-Ring; Humans; Integrin alphaVbeta3; Melanoma; Proto-Oncogene Proteins c-akt; Radiation Tolerance; Signal Transduction; Skin Neoplasms; Snake Venoms

2020